Alice Jacobs, M.D., Caltech EIR, Third Rock Ventures. Dr. Jacobs serves as EIR at Caltech, FiNC Technologies, Third Rock Ventures/MIT/Bob Langer, GE Healthcare Ventures, Greybird Ventures and Essex Management. Advisory/investor roles include artificial intelligence/machine learning/big data in digital health/wellness, microbiome, clean energy, synthetic biology, genomics, liquid biopsy and other precision medicine technologies, drug discovery/development platforms and gene editing. This includes a platform technology in the top 10 recommendations of the Blue Ribbon Panel on the cancer moonshot to speed progress in cancer.
While still a student at Harvard Medical School, Dr. Jacobs co-founded IMDx along with Dr Boris Nikolic (Chief Science and Technology Advisor to Bill Gates and Managing Director, Biomatics Capital.) IMDx became an industry leader globally in the development and manufacturing of molecular diagnostic tests, prior to exit.
Dr. Jacobs holds multiple patents in personalized medicine and has received numerous awards including being recognized by Scientific American as one of the top 50 innovators and by the World Economic Forum as a Young Global Leader, a 40 under 40 award by the Boston Business Journal as well as for Healthcare Innovation in Clinical Diagnostics by Frost & Sullivan. She holds a BA in Art History, a BS in Biological Sciences from Stanford with Honors in Developmental Neurobiology and an MD from Harvard Medical School.